Today’s pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry’s major underlying drivers — higher rates of cancer and chronic disease — are still at play and not expected to dissipate. The US reigns supreme…
Locksley Resources (LKY:AU) has announced High Grade Mineralised Corridor at the Mojave Project Download the PDF here. This post…
Investor Insight Centurion Minerals offers investors an early-stage entry point into a strategically located gold exploration company positioned within…
From established players to up-and-coming firms, Canada’s pharmaceutical landscape is diverse and dynamic. Canadian drug companies are working to…
Altech Batteries (ATC:AU) has announced Altech – CERENERGY Project Secures German Grant Approval Download the PDF here. This post…
The lithium market heads into 2026 after one of its most punishing years in recent memory, shaped by deep…
Carbonxt Group (CG1:AU) has announced Placement to Fund Further Investment in New Carbon Download the PDF here. This post…
Asara Resources (AS1:AU) has announced Ongoing drilling continues to return broad gold intercepts Download the PDF here. This post…